ABSTRACT

Pharmacoeconomics is a young field-the term itself did not exist when most of the authors of this book began their careers. And yet, it may die as quickly as it arose because we have largely failed to address the questions that actual decision makers ask. If pharmacoeconomics is to have as vibrant a future as has been its short past, it must meet the substantial challenges posed in providing the information that is really needed.